Drug-Induced Lupus Secondary to Ethosuximide in Association with Acute Tubulointerstitial Nephritis and Nephrotic Syndrome
Abstract
Share and Cite
Aly, R.; Zeng, X.; Upadhyay, K. Drug-Induced Lupus Secondary to Ethosuximide in Association with Acute Tubulointerstitial Nephritis and Nephrotic Syndrome. Pediatr. Rep. 2022, 14, 190-199. https://doi.org/10.3390/pediatric14020026
Aly R, Zeng X, Upadhyay K. Drug-Induced Lupus Secondary to Ethosuximide in Association with Acute Tubulointerstitial Nephritis and Nephrotic Syndrome. Pediatric Reports. 2022; 14(2):190-199. https://doi.org/10.3390/pediatric14020026
Chicago/Turabian StyleAly, Rasha, Xu Zeng, and Kiran Upadhyay. 2022. "Drug-Induced Lupus Secondary to Ethosuximide in Association with Acute Tubulointerstitial Nephritis and Nephrotic Syndrome" Pediatric Reports 14, no. 2: 190-199. https://doi.org/10.3390/pediatric14020026
APA StyleAly, R., Zeng, X., & Upadhyay, K. (2022). Drug-Induced Lupus Secondary to Ethosuximide in Association with Acute Tubulointerstitial Nephritis and Nephrotic Syndrome. Pediatric Reports, 14(2), 190-199. https://doi.org/10.3390/pediatric14020026

